We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACCD
2376
DELISTED
Accolade Inc
ACCD
| $85.2K | ﹤0.01% |
23,792
-53,692
| -69% | -$407K |
|
2377
FibroBiologics
FBLG
$4.33M
| $83.3K | ﹤0.01% |
835
-1,766
| -68% | -$337K |
|
2378
Design Therapeutics
DSGN
$736M
| $81.3K | ﹤0.01% |
+24,280
| New | +$94.6K |
|
2379
Vor Biopharma
VOR
$1.04B
| $81.1K | ﹤0.01% |
4,056
+240
| +6% | +$7.76K |
|
|
CLSD
2380
DELISTED
Clearside Biomedical
CLSD
| $80.8K | ﹤0.01% |
4,141
-423
| -9% | -$8.17K |
|
2381
Rani Therapeutics
RANI
$95.6M
| $80.7K | ﹤0.01% |
+21,247
| New | +$110K |
|
2382
Companhia Siderúrgica Nacional
SID
$1.43B
| $80.7K | ﹤0.01% |
+35,082
| New | +$92.4K |
|
2383
AXT Inc
AXTI
$3.09B
| $78.1K | ﹤0.01% |
23,102
-50,881
| -69% | -$178K |
|
2384
Kyverna Therapeutics
KYTX
$450M
| $78K | ﹤0.01% |
10,400
-145,355
| -93% | -$2.22M |
|
|
BRAG
2385
Bragg Gaming Group
BRAG
$43M
| $77.3K | ﹤0.01% |
+13,395
| New | +$80.6K |
|
|
OTLY
2386
Oatly Group
OTLY
$417M
| $76.9K | ﹤0.01% |
4,090
-7,895
| -66% | -$168K |
|
2387
Shoals Technologies Group
SHLS
$1.58B
| $75.5K | ﹤0.01% |
12,100
-4,200
| -26% | -$33.5K |
|
2388
KVH Industries
KVHI
$177M
| $74.8K | ﹤0.01% |
+16,089
| New | +$80.2K |
|
|
IMA
2389
ImageneBio Inc
IMA
$63.1M
| $74.1K | ﹤0.01% |
3,744
-3,647
| -49% | -$64.4K |
|
|
PGRE
2390
DELISTED
Paramount Group
PGRE
| $73.6K | ﹤0.01% |
+15,900
| New | +$73.7K |
|
|
ONTF
2391
DELISTED
ON24
ONTF
| $71.6K | ﹤0.01% |
+11,921
| New | +$75.7K |
|
|
ASRT
2392
DELISTED
Assertio
ASRT
| $70.1K | ﹤0.01% |
+3,767
| New | +$56K |
|
|
HBI
2393
DELISTED
Hanesbrands
HBI
| $70K | ﹤0.01% |
+14,200
| New | +$69.6K |
|
2394
Cerus
CERS
$587M
| $69.8K | ﹤0.01% |
39,665
-162,913
| -80% | -$291K |
|
2395
Vivid Seats
SEAT
$77M
| $67.3K | ﹤0.01% |
+585
| New | +$63.6K |
|
|
VOXX
2396
DELISTED
VOXX International Corporation Class A
VOXX
| $66.8K | ﹤0.01% |
+21,151
| New | +$113K |
|
2397
Caterpillar
CAT
$409B
| $66.6K | ﹤0.01% |
+200
| New | +$69.3K |
|
2398
Traeger
COOK
$170M
| $66.5K | ﹤0.01% |
554
| – | – |
|
2399
Stereotaxis
STXS
$129M
| $65.9K | ﹤0.01% |
36,209
-93,552
| -72% | -$210K |
|
2400
CDT Equity Inc
CDT
$1.93M
| – | – |
0
| – | – |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.